Skip to main content Help with accessibility Skip to main navigation

TICAGRELOR tablets (Brilique®)

CCG Approval Status:

Date Added: 22 - May - 2019
Body System:
Amber initiated

The Pan Mersey Area Prescribing Committee recommends the prescribing of TICAGRELOR tablets (Brilique®), following specialist initiation, for the management of acute coronary syndromes in adults in accordance with NICE TA236 and for preventing atherothrombotic events after myocardial infarction in accordance with NICE TA420.

GP support resource